Fair Value Measurements of Financial Instruments (Tables)

12 Months Ended

Jan. 01, 2022

Fair Value Disclosures [Abstract]

Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis Table

Financial instruments measured at fair value were as follows (in thousands):

	Fair value as of measurement date		Quoted prices in active markets for identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Balance as of January 1, 2022
Cash and cash equivalents (including money market funds) (1)	$	52,270	$	52,270	$	—	$	—
Government securities (2)	$	5,489	$	—	$	5,489	$	—
Corporate bonds (2)	$	7,816	$	—	$	7,816	$	—
Derivative financial instruments - liability (3)	$	(959)	$	—	$	(959)	$	—
Deferred stock-based compensation (4)	$	(8,079)	$	—	$	(8,079)	$	—
Put option liability (5)	$	(5,100)	$	—	$	—	$	(5,100)
Balance as of January 2, 2021
Cash and cash equivalents (including money market funds) (1)	$	116,120	$	116,120	$	—	$	—
Government securities (2)	$	6,371	$	—	$	6,371	$	—
Corporate bonds (2)	$	7,228	$	—	$	7,228	$	—
Derivative financial instruments - liability (3)	$	(2,328)	$	—	$	(2,328)	$	—
Deferred stock-based compensation (4)	$	(7,207)	$	—	$	(7,207)	$	—

Amounts in parentheses indicate liabilities.

The index below indicates the line item in the Consolidated Balance Sheets where the financial instruments are reported:

(1) "Cash and cash equivalents"

(2) Current portion - "Short-term investments"; Long-term portion - "Other Assets"

(3) Current portion - "Accounts payable and accrued expenses"; Long-term portion - "Other Long-Term Liabilities"

(4) Current portion - "Current maturities of other long-term obligations"; Long-term portion - "Other Long-Term Liabilities"

(5) "Other Long-Term Liabilities"